Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation.

Abstract

We examined the outcome of a cohort of patients with Hodgkin lymphoma (HL) in order to assess if fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) at the end of treatment (end-PET) can be omitted when the interim PET (int-PET) is negative. Seventy-six ABVD(adriamycin, bleomycin, vinblastine, dacarbazine)-treated patients… (More)
DOI: 10.1111/bjh.14292

Topics

Cite this paper

@article{Mesguich2016HodgkinLA, title={Hodgkin lymphoma: a negative interim-PET cannot circumvent the need for end-of-treatment-PET evaluation.}, author={Charles Mesguich and Anne-Laure Cazeau and Krimo Bouabdallah and Pierre Soubeyran and Martine Guyot and N{\"o}el Milpied and Laurence Bordenave and Elif Hindi{\'e}}, journal={British journal of haematology}, year={2016}, volume={175 4}, pages={652-660} }